Stada rises on market talk of bid by Teva
FRANKFURT (Reuters) - Shares in German generic drugmaker Stada Arzneimittel (STAGn.DE) rose as much as 4 percent as traders pointed to market talk that larger rival Teva (TEVA.TA) could make an offer at 42 euros ($56.78) per share.
The shares were up 1.6 percent at 35.51 euros at 1421 GMT on Tuesday, more than two hours ahead of the market close, with trading volumes at more than twice the one-day average over the past three months.
Stada and Teva declined to comment.
- U.S. nurse defies Maine's Ebola quarantine, takes bike ride |
- Clashes erupt as Israeli police kill Palestinian suspected of shooting Jewish far-rightist
- Apple's Cook: 'I'm proud to be gay'
- SoftBank's humanoid robot lands job as Nescafe salesman
- Ukraine, Russia, EU likely to agree gas supply deal Thursday: officials